Search results for p16INK4a

CDKN2A / p16INK4a antibody [GT1249], Genetex, GTX635638

CDKN2A / p16INK4a antibody [GT888], Genetex, GTX635639

CDKN2A / p16INK4a (phospho Ser326) antibody, Genetex, GTX32378

CDKN2A / p16INK4a antibody [G175-405], Genetex, GTX01783

CDKN2A/p16INK4a Antibody (YA4018)(PBS only), MedChemexpress, HY-P84321A

CDKN2A/p16INK4a Antibody (YA4018) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to CDKN2A/p16INK4a.

[KO Validated] CDKN2A/p16INK4a Rabbit mAb, ABclonal, A11651

[KO Validated] CDKN2A/p16INK4a Rabbit mAb, ABclonal, A25904

CDKN2A / p16INK4a antibody [MSVA-016R] HistoMAX™, Genetex, GTX04442

[KO Validated] CDKN2A/p16INK4a Rabbit pAb- ABclonal, ABclonal, A0262

p16INK4a Antibody, Abbexa, abx026389

This gene generates several transcript variants which differ in their first exons. At least three alternatively spliced variants encoding distinct proteins have been reported, two of which encode structurally related isoforms known to function as inhibitors of CDK4 kinase. The remaining transcript includes an alternate first exon located 20 Kb upstream of the remainder of the gene; this transcript contains an alternate open reading frame (ARF) that specifies a protein which is structurally unrelated to the products of the other variants. This ARF product functions as a stabilizer of the tumor suppressor protein p53 as it can interact with, and sequester, MDM1, a protein responsible for the degradation of p53. In spite of the structural and functional differences, the CDK inhibitor isoforms and the ARF product encoded by this gene, through the regulatory roles of CDK4 and p53 in cell cycle G1 progression, share a common functionality in cell cycle G1 control. This gene is frequently mutated or deleted in a wide variety of tumors, and is known to be an important tumor suppressor gene.